Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 341-346

  Gray, Carolyn M ^a   McCorkell, Kelly A ^a   Chunduru, Srinivas K ^b   McKinlay, Mark A ^c   May, Michael J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PKPD Bioscience   (United States)

^c Task Force for Global Health   (United States)

Author keywords

Bortezomib; cIAP; NF B; NIK; Proteasome; Smac mimetic

Indexed keywords

CELLULAR INHIBITOR OF APOPTOSIS 1; CELLULAR INHIBITOR OF APOPTOSIS 2; ENZYME; I KAPPA B KINASE ALPHA; NUCLEAR FACTOR KAPPA B INDUCING KINASE; PROTEASOME; PROTEIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME STABILITY; HELA CELL LINE; MOLECULAR BIOLOGY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION;

BORTEZOMIB; CIAP; NF-ΚB; NIK; PROTEASOME; SMAC MIMETIC;

3T3 CELLS; ANIMALS; ENZYME ACTIVATION; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; MICE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES;

EID: 84904734600     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.05.122     Document Type: Article

References (31)

1. M.S. Hayden, and S. Ghosh Shared principles in NF-kappaB signaling Cell 132 2008 344 362
2. M.S. Hayden, and S. Ghosh NF-kappaB in immunobiology Cell Res. 21 2011 223 244
3. S.C. Sun Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling Sci. Signal. 3 2010 pe18
4. S.C. Sun Non-canonical NF-kappaB signaling pathway Cell Res. 21 2011 71 85
5. S.C. Sun The noncanonical NF-kappaB pathway Immunol. Rev. 246 2012 125 140
6. B. Razani, A.D. Reichardt, and G. Cheng Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives Immunol. Rev. 244 2011 44 54
7. Y.M. Thu, and A. Richmond NF-kappaB inducing kinase: a key regulator in the immune system and in cancer Cytokine Growth Factor Rev. 21 2010 213 226
8. G. Qing, Z. Qu, and G. Xiao Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100 J. Biol. Chem. 280 2005 40578 40582
9. G. Liao, M. Zhang, E.W. Harhaj, and S.C. Sun Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation J. Biol. Chem. 279 2004 26243 26250
10. S. Vallabhapurapu, A. Matsuzawa, W. Zhang, P.H. Tseng, J.J. Keats, H. Wang, D.A. Vignali, P.L. Bergsagel, and M. Karin Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling Nat. Immunol. 9 2008 1364 1370
11. B.J. Zarnegar, Y. Wang, D.J. Mahoney, P.W. Dempsey, H.H. Cheung, J. He, T. Shiba, X. Yang, W.C. Yeh, T.W. Mak, R.G. Korneluk, and G. Cheng Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK Nat. Immunol. 9 2008 1371 1378
12. E. Varfolomeev, T. Goncharov, H. Maecker, K. Zobel, L.G. Komuves, K. Deshayes, and D. Vucic Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors Sci. Signal. 5 2012 ra22
13. H. Sanjo, D.M. Zajonc, R. Braden, P.S. Norris, and C.F. Ware Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor J. Biol. Chem. 285 2010 17148 17155
14. J. Liu, A. Sudom, X. Min, Z. Cao, X. Gao, M. Ayres, F. Lee, P. Cao, S. Johnstone, O. Plotnikova, N. Walker, G. Chen, and Z. Wang Structure of the nuclear factor kappaB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation J. Biol. Chem. 287 2012 27326 27334
15. U. Senftleben, Y. Cao, G. Xiao, F.R. Greten, G. Krahn, G. Bonizzi, Y. Chen, Y. Hu, A. Fong, S.C. Sun, and M. Karin Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway Science 293 2001 1495 1499
16. E. Dejardin, N.M. Droin, M. Delhase, E. Haas, Y. Cao, C. Makris, Z.W. Li, M. Karin, C.F. Ware, and D.R. Green The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways Immunity 17 2002 525 535
17. B. Razani, B. Zarnegar, A.J. Ytterberg, T. Shiba, P.W. Dempsey, C.F. Ware, J.A. Loo, and G. Cheng Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation Sci. Signal. 3 2010 ra41
18. A. Matsushima, T. Kaisho, P.D. Rennert, H. Nakano, K. Kurosawa, D. Uchida, K. Takeda, S. Akira, and M. Matsumoto Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I J. Exp. Med. 193 2001 631 636
19. A.F. Kisselev, W.A. van der Linden, and H.S. Overkleeft Proteasome inhibitors: an expanding army attacking a unique target Chem. Biol. 19 2012 99 115
20. A.L. Goldberg Development of proteasome inhibitors as research tools and cancer drugs J. Cell Biol. 199 2012 583 588
21. E. Varfolomeev, J.W. Blankenship, S.M. Wayson, A.V. Fedorova, N. Kayagaki, P. Garg, K. Zobel, J.N. Dynek, L.O. Elliott, H.J. Wallweber, J.A. Flygare, W.J. Fairbrother, K. Deshayes, V.M. Dixit, and D. Vucic IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis Cell 131 2007 669 681
22. C.M. Annunziata, R.E. Davis, Y. Demchenko, W. Bellamy, A. Gabrea, F. Zhan, G. Lenz, I. Hanamura, G. Wright, W. Xiao, S. Dave, E.M. Hurt, B. Tan, H. Zhao, O. Stephens, M. Santra, D.R. Williams, L. Dang, B. Barlogie, J.D. Shaughnessy Jr., W.M. Kuehl, and L.M. Staudt Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma Cancer Cell 12 2007 115 130
23. P. Dhawan, Y. Su, Y.M. Thu, Y. Yu, P. Baugher, D.L. Ellis, T. Sobolik-Delmaire, M. Kelley, T.C. Cheung, C.F. Ware, and A. Richmond The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells J. Biol. Chem. 283 2008 15399 15408
24. J.J. Keats, R. Fonseca, M. Chesi, R. Schop, A. Baker, W.J. Chng, S. Van Wier, R. Tiedemann, C.X. Shi, M. Sebag, E. Braggio, T. Henry, Y.X. Zhu, H. Fogle, T. Price-Troska, G. Ahmann, C. Mancini, L.A. Brents, S. Kumar, P. Greipp, A. Dispenzieri, B. Bryant, G. Mulligan, L. Bruhn, M. Barrett, R. Valdez, J. Trent, A.K. Stewart, J. Carpten, and P.L. Bergsagel Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma Cancer Cell 12 2007 131 144
25. D.B. Conze, Y. Zhao, and J.D. Ashwell Non-canonical NF-kappaB activation and abnormal B cell accumulation in mice expressing ubiquitin protein ligase-inactive c-IAP2 PLoS Biol. 8 2010 e1000518
26. J. Jin, Y. Xiao, J.H. Chang, J. Yu, H. Hu, R. Starr, G.C. Brittain, M. Chang, X. Cheng, and S.C. Sun The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-kappaB signaling Nat. Immunol. 13 2012 1101 1109
27. C.M. Pickart Targeting of substrates to the 26S proteasome FASEB J. 11 1997 1055 1066
28. D. Finley Recognition and processing of ubiquitin-protein conjugates by the proteasome Annu. Rev. Biochem. 78 2009 477 513
29. C.M. Gray, C. Remouchamps, K.A. McCorkell, L.A. Solt, E. Dejardin, J.S. Orange, and M.J. May Noncanonical NF-kappaB signaling is limited by classical NF-kappaB activity Sci. Signal. 7 2014 ra13
30. P. Tsvetkov, N. Reuven, and Y. Shaul Ubiquitin-independent p53 proteasomal degradation Cell Death Differ. 17 2010 103 108
31. G. Asher, N. Reuven, and Y. Shaul 20S proteasomes and protein degradation "by default" BioEssays 28 2006 844 849